Cognoa is a pediatric behavioral health company developing digital diagnostics and therapeutics to enable the earlier diagnosis and treatment of behavioral health conditions, such as autism. We are dedicated to improving lifelong outcomes for children at risk for developmental delay and their families. Our lead products, the first digital diagnosis aid for autism and the first prescription digital therapeutic for children diagnosed with autism, have both received Breakthrough Device designation from the FDA. The company’s AI technology platform will enable Cognoa's product pipeline to address additional unmet needs including ADHD and anxiety. Cognoa plans to commercialize its autism diagnosis aid under the name, Canvas Dx™. For additional information and to receive updates on availability for Canvas Dx™, please visit CanvasDx.com.
Location: United States, California, Palo Alto
Employees: 51-200
Total raised: $11.6M
Founded date: 2013
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.03.2017 | - | $11.6M | - |
Mentions in press and media 32
| Date | Title | Description | Source |
| 08.11.2023 | Alarming Wait Times and Persistent Inequities Obstructing Ea... | What You Should Know: Cognoa, a leading child development and behavioral health company, today publi... | hitconsult... |
| 14.02.2022 | Healthcare Industry Still Lacks Inclusivity And Accessibilit... | A community health worker at Bangladesh, Mobarakdi Village, showing women how to use a condom Univer... | forbes.com... |
| 22.12.2021 | SOFTWARE AS A MEDICAL DEVICE (SaMD) Часть 3: сертифицированн... | SOFTWARE AS A MEDICAL DEVICE (SaMD) Часть 3: сертифицированные MedTech стартапы на основе искусствен... | startupjed... |
| 22.12.2021 | SOFTWARE AS A MEDICAL DEVICE (SaMD) Part 3: Certified AI-bas... | SOFTWARE AS A MEDICAL DEVICE (SaMD) Part 3: Certified AI-based MedTech Startups | startupjed... |
| 30.09.2021 | Cognoa : Appoints Seasoned Financial Executive, Tony Rimac, ... | PALO ALTO, Calif., Sept. 30, 2021 /PRNewswire/ -- Cognoa, a pediatric behavioral health company deve... | marketscre... |
| 04.06.2021 | Cognoa Receives FDA Marketing Authorization for First-of-Its... | Cognoa’s AI-Driven Device Is the First FDA-Authorized Diagnosis Aid Designed to Help Primary Care Ph... | aithority.... |
| 05.02.2021 | Executive Hires: Walgreens Appoints New CEO, Cityblock Healt... | Walgreens appoints Rosalind (Roz) Brewer as the company’s Chief Executive Officer, effective on Marc... | hitconsult... |
| 06.10.2020 | This AI Tool For Diagnosing Autism Could Hit The Market ‘In ... | WHITE OAK, MD - JULY 20: A sign for the Food And Drug Administration is seen outside of the ... [+] ... | forbes.com... |
| 19.03.2020 | Can AI Help With Autism Diagnosis? | An Interview with Cognoa’s CEO Brent Vaughan | forbes.com... |
| 25.10.2019 | Cognoa Launches Pivotal Study of Diagnostic Aid for Autism | – Cognoa launches a pivotal study to demonstrate the effectiveness of its diagnostic aid for autism ... | hitconsult... |
Show more